Fosamprenavir

Telzir 50 MG/ML Suspension Oral

50 mg suspensión oralSpainWithdrawnAuthorised 21 Jul 2004

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fosamprenavir

Telzir 50 MG/ML Suspension Oral

50 mg suspensión oralSpainWithdrawnAuthorised 21 Jul 2004

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LexivaUnited States · 50MG BASE/ML · suspension · Viiv Hlthcare

Fosamprenavir CalciumUnited States · 700MG, 700MG BASE · tablet · Lupin LTD

LexivaUnited States · 700MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Viiv Hlthcare

Packs

Pack	Code	Status
TELZIR 50 MG/ML SUSPENSION ORAL, 1 frasco de 225 ml	819482

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Fosamprenavir
Strength: 50 mg
Dosage form: suspensión oral
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 21 Jul 2004
Registration: 04282002
Marketing authorisation holder: Viiv Healthcare B.V.
Procedure: EU centralised
Supply: Diagnóstico Hospitalario